StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$18.18−0.79 (-4.16%)

Close on Nov 17, 2026Market cap $1.12BP/E –Yield –

Vor Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Vor Biopharma's pe ratio was 1.7× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×–

More Vor Biopharma figures

See a number that looks wrong?